Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CsgA (major curlin subunit) is the primary structural component of curli, functional amyloid fibers produced on the surface of gram-negative bacteria, particularly *Escherichia coli*[1][2]. Upon secretion through the outer membrane CsgG–CsgE–CsgF complex, CsgA monomers are nucleated by the minor subunit CsgB and assemble into a non-centrosymmetric beta-helical fibril architecture stabilized by hydrogen bonding between five amyloidogenic repeats[1][3]. These curli fibers are integral to bacterial biofilm formation, enabling cell adhesion, surface colonization, and host invasion[2][3]. While CsgA itself is not a therapeutic target in the traditional sense, understanding its structure and assembly mechanisms provides insights relevant to preventing biofilm-associated infections and potentially developing novel anti-biofilm strategies. Additionally, CsgA serves as a model for studying regulated functional amyloid production, with implications for understanding pathological amyloid diseases in humans[2].
CsgA assembly involves: - Nucleation-precipitation mechanism: Unfolded CsgA subunits in solution are nucleated by CsgB (minor subunit), causing ordered assembly into fibers in the extracellular space - Secretion via Type VIII system: CsgA is secreted through the CsgG–CsgE–CsgF complex (outer membrane pore), where accessory proteins CsgE and CsgF regulate controlled export - Chaperone regulation: CsgC (periplasmic chaperone) and CsgE (secretion chaperone) prevent premature amyloid formation and direct CsgA toward secretion - Electrostatic interactions: CsgA contains 10 acidic amino acids and only 4 basic amino acids, enabling negatively charged surface interactions with positively charged regions of chaperone proteins
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Major curlin subunit (CsgA) (CsgA).